Evaluation of S100A8/A9 and neutrophils as prognostic markers in metastatic melanoma patients under immune-checkpoint inhibition
Authors:
- Yasmin F MelzerYasmin F Melzer
- Nadine L FergenNadine L Fergen
- Christian MessChristian Mess
- Julia-Christina StadlerJulia-Christina Stadler
- Glenn GeidelGlenn Geidel
- Ysabel A SchwietzerYsabel A Schwietzer
- Julian KöttJulian Kött
- Klaus PantelKlaus Pantel
- Stefan W SchneiderStefan W Schneider
- Jochen UtikalJochen Utikal
- Ewa WladykowskiEwa Wladykowski
- Sabine Vidal-Y-SySabine Vidal-Y-Sy
Open Access
- 18 December 2024
- journal article
- Published by Elsevier in Translational Oncology
- Vol. 52, 102224
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- CXCR1 and CXCR2 Chemokine Receptor Agonists Produced by Tumors Induce Neutrophil Extracellular Traps that Interfere with Immune CytotoxicityImmunity, 2020
- Peripheral blood clinical laboratory variables associated with outcomes following combination nivolumab and ipilimumab immunotherapy in melanomaCancer Medicine, 2018
- Resistance to PD1/PDL1 checkpoint inhibitionCancer Treatment Reviews, 2017
- Neutrophils in the Tumor MicroenvironmentTrends in Immunology, 2016
- Neutrophil extracellular traps in cancer progressionCellular and Molecular Life Sciences, 2014
- Targeting Damage-Associated Molecular Pattern Molecules (DAMPs) and DAMP Receptors in Melanoma2013
- Immunomonitoring and prognostic relevance of neutrophils in clinical trialsSeminars in Cancer Biology, 2013
- Intratumoral neutrophils and plasmacytoid dendritic cells indicate poor prognosis and are associated with pSTAT3 expression in AJCC stage I/II melanomaCancer, 2011
- S100A8 and S100A9 in inflammation and cancerBiochemical Pharmacology, 2006
- MRP-8 and MRP-14, two abundant Ca2+-binding proteins of neutrophils and monocytesJournal of Leukocyte Biology, 1993